Yin-Yang Balance of ACE/ACE2 Pathways: The Rational for ACE2 Pathway Inhibitor Administration in SARS-CoV-2 Patients [post]

Loris Zamai
2020 unpublished
The article describes the rational for inhibition of the angiotensin-converting enzyme 2 (ACE2) pathways as specific targets in patients infected by SARS-CoV-2.
doi:10.20944/preprints202003.0338.v1 fatcat:uuzabibgengifkhbztnlvd64xi